Expression of Mutated p53 Occurs in Ttimor-distant Epithelia of Head and Neck Cancer Patients: A Possible Molecular Basis for the Development of Multiple Ttamors

Cancer Research

Volumn 53, Issue 18, 1993, Pages 4189-4196

  Nees, Matthias ^a   Homann, Nils ^a   Discher, Hilde ^a   Andl, Thomas ^a   Enders, Christel ^a   Herold Mende, Christel ^a   Schuhmann, Antje ^a   Bosch, Franz X ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; DNA; HISTONE H3; PROTEIN P53;

ARTICLE; CANCER LOCALIZATION; CARCINOGENESIS; CONTROLLED STUDY; DNA POLYMORPHISM; GENE EXPRESSION; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MULTIPLE CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY EPITHELIUM; SQUAMOUS EPITHELIUM;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL DIVISION; CODON; GENES, P53; HEAD AND NECK NEOPLASMS; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; POLYMERASE CHAIN REACTION; PROTEIN P53; SUPPORT, NON-U.S. GOV'T;

EID: 0027853193     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Million, R.B.M. Cassisi, N.J., and Clark, J.R. Cancer of the head and neck. In: V.T. DeVita, Jr., S. Hellman, and S.A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 488-590. Philadelphia: J.B. Lippincott Company, 1989.
2. Pindborg, J.J. Control of oral cancer in developing countries. Bull. WHO, 62: 817-830, 1984.
3. Snow, G.B., and de Vries, N. Zweittumoren bei patienten mit plattenepithelkarzi-nomen im kopf-hals-bereich. In: H. Maier and H. Weidauer (eds.), Krebsrisiken im Kopf-Hals-Bereich, S 185-194. Berlin: Springer-Verlag, 1991.
4. Stanbridge, E.J. Identifying tumor suppressor genes in human colorectal cancer. Science (Washington DC), 247: 12-13, 1990.
5. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. p. 3 mutations in human cancer. Science (Washington DC), 253: 49-53, 1991.
6. Weinberg, R.A. Tumor suppressor genes. Science (Washington DC), 254: 1138-1145, 1991.
7. Lane, D.P. p. 3, guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
8. Vogelstein, B., and Kinzler, K.W. p. 3 function and dysfunction. Cell, 70: 523-526, 1992.
9. Hartwell, L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell, 71: 543-546, 1992.
10. Field, J.K. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur. J. Cancer, 28 B: 67-76, 1992.
11. Kern, S.E., Pietenpol, J.A., Thiagalingam, S., Seymour, A., Kinzler, K.W., and Vogelstein, B. Oncogenic forms of p. 3 inhibit p. 3-regulated gene expression. Science (Washington DC), 256: 827-830, 1992.
12. Gannon, J.V., Greaves, R., Iggo, R., and Lane, D.P. Activating mutations in p. 3 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J., 9: 1595-1602, 1990.
13. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Butel, J.S., and Bradley, A. Mice deficient for p. 3 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.), 356: 215-221, 1992.
14. Maltzman, W., and Czyzyk, L. UV irradiation stimulates levels of p. 3 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol., 4: 1689-1694, 1984.
15. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R.W. Participation of p. 3 protein in the cellular response to DNA damage. Cancer Res., 57: 6304-6311, 1991.
16. Hall, P.A., McKee, P.H., Menage, H.D., Dover, R., and Lane, D.P. High levels of p. 3 protein in UV irradiated human skin. Oncogene, 8: 203-207, 1993.
17. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p. 3. Cell, 70: 923-935, 1992.
18. Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C., and Wahl, G.M. Wild-type p. 3 restores cell cycle control and inhibits gene amplification in cells with mutant p. 3 alleles. Cell, 70: 937-948, 1992.
19. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A., and Jacks, T. p. 3 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
20. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L., and Wyllie, A.H. Thymocyte apoptosis induced by p. 3-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
21. Lane, D.P. Cancer: a death in the life of p. 3. Nature (Lond.), 362: 786-787, 1993.
22. Tlsty, T.D., Margolin, B.H., and Lum, K. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbriick fluctuation analysis. Proc. Natl. Acad. Sci. USA, 86: 9441-9445, 1989.
23. Tlsty, T.D., White, A., and Sanchez, J. Suppression of gene amplification in human cell hybrids. Science (Washington DC), 255: 1425-1427, 1992.
24. Wright, J.A., Smith, H.S., Watt, F.M., Hancock, M.C., Hudson, D.L., and Stark, G.R. DNA amplification is rare in normal human cells. Proc. Natl. Acad. Sci. USA, 87: 1791-1795, 1990.
25. Baker, S.J., Preisinger, A.C., Jessup, J.M., Paraskeva, C., Markowitz, S., Willson, J.K.V., Hamilton, S., and Vogelstein, B. p. 3 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722, 1990.
26. Vogelstein, B. A deadly inheritance. Nature (Lond.), 348: 681-682, 1990.
27. Sundaresan, V., Ganly, P., Hasleton, P., Rudd, R., Sinha, G., Bleehen, N.M., and Rabbitts, P. p. 3 and chromosome abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene, 7: 1989-1997, 1992.
28. Sozzi, G., Miozzo, M., Donghi, R., Pilotti, S., Cariani, C.T., Pastorino, U., Delia Porta, G., and Pierotti, M.A. Deletions of 17p and p. 3 mutations in preneoplastic lesions of the lung. Cancer Res., 52: 6079-6082, 1992.
29. Bennett, W.P., Hollstein, M.C., Metcalf, R.A., Welsh, J.A., He, A., Zhu, S.M., Kusters, I., Resau, J.H., Trump, B.F., Lane, D.P., and Harris, C.C.p. 3 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res., 52: 6092-6097, 1992.
30. von Deimling, A., Eibl, R.H., Ohgaki, H., Louis, D.N., \bn Ammon, K., Peterson, I., Kleihues, P., Chung, R.Y., Wiestler. O.D., and Seizinger, B.R. p. 3 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res., 52: 2987-2990, 1992.
31. Pignatelli, M., Stamp, G.W.H., Kafiri, G., Lane, D.P., and Bodmer, W.F. Over-expression of p. 3 nuclear oncoprotein in colorectal adenomas. Int. J. Cancer, 50: 683-688, 1992.
32. Sakai, E., and Tsuchida, N. Most human squamous cell carcinomas in the oral cavity contain mutated p. 3 tumor-suppressor genes. Oncogene, 7: 927-933, 1992.
33. Maestro, R., Dolcetii, R., Gasparotto, D., Dolglioni, C., Pelucchi, S., Barzan, L., Grandi, E., and Boiocchi, M. High frequency of p. 3 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene, 7: 1159-1166, 1992.
34. Somers, K.D., Merrick, M.A., Incognito, L.S., Schechter, G.L., and Casey, G. Frequent p. 3 mutations in head and neck cancer. Cancer Res., 52: 5997-6000, 1992.
35. Brachmann, D.G., Graves, D., Vokes, E., Beckett, M., Haraf, D., Montag, A., Dunphy, E., Mick, R., Yandell, D., and Weichselbaum, R.R. Occurrence of p. 3 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res., 52: 4832-4836, 1992.
36. Ogden, G.R., Kiddie, R.A., Lunny, D.P., and Lane, D.P. Assessment of p. 3 protein expression in normal, benign, and malignant oral mucosa. J. Pathol., 166: 389-394, 1992.
37. Gusterson, B.A., Anbazhagan, R., Warren, W., Midgely, C., Lane, D.P., O'Hare, M., Stamps, A., Carter, R., and Jayatilake, H. Expression of p. 3 in premalignant and malignant squamous epithelium. Oncogene, 6: 1785-1789, 1991.
38. Dolcetti, R., Doglioni, C., Maestro, R., Gasparotto, D., Bazan, L., Pastore, A., Ro-manelli, M., and Boiocchi, M. p. 3 overexpression is an early event in the development of human squamous cell carcinoma of the larynx: genetic and prognostic implications. Int. J. Cancer, 52: 178-182, 1992.
39. Bartkova, J., Bartek, J., Lukas, J., Vojtesek, B., Staskova, Z., Rejthar, A., Kovarik, J., Midgeley, C.A., and Lane, D.P. p. 3 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int. J. Cancer, 49: 196-202, 1991.
40. Banks, L., Matlashewski, G., and Crawford, L. Isolation of human p. 3 specific monclonal antibodies and their use in the studies of human p. 3 expression. Eur. J. Biochem., 759: 529-534, 1986.
41. Bosch, F.X., Ouhayoun, J.R., Bader, B.L., Collin, C., Grand, C., Lee, I., and Franke, W.W. Extensive changes in cytokeratin expression patterns in pathologically affected human gingiva. Virchows Arch. B Cell. Pathol., 58: 59-77, 1989.
42. Bosch, F.X., Leube, R.E., Achtstatter, T., Moll, R., and Franke, W. W Expression of simple epithelial type cytokeratins in stratified epithelia as detected by immunolo-calization and hybridization in situ. J. Cell Biol., 706: 1635-1648, 1988.
43. Bosch, F.X., Durst, M., Schwarz, E., Boukamp, P., Fusenig, N.E., and zur Hausen, H. The early genes E6 and E7 of cancer associated human papilloma viruses as targets of tumor suppression. Behring Inst. Mitt., 89: 108-121, 1991.
44. Bosch, F.X., Udvarhelyi, N., Venter, E., Herold-Mende, C., Schuhmann, A., Maier, H., Weidauer, H., and Born, A.I. Expression of the histone H3 gene in benign, semi-malignant and malignant lesions of the head and neck: a reliable proliferation marker. Eur. J. Cancer, 29AI10: 1454-1461, 1993.
45. Orita, M., Youichi, S., Seiya, T., and Hayashi, K. Rapid sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
46. Moll, R., Franke, W.W., Schiller, D.L., Geiger, B., and Kepler, R. The catalog of human cytokeratin polypeptides: patterns of expression of specific cytokeratins in normal epithelia, tumors and cultured cells. Cell, 57: 11-24, 1982.
47. Franke, W.W., Moll, R., Achstatter, T., and Kuhn, C. Cell typing of epithelia and carcinomas of the female genital tract using cytoskeletal proteins as markers. In: R. Peto and H. zur Hausen (eds.), Viral Etiology of Cervical Cancer, Banbury Report 21, pp. 121-148. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1986.
48. Morgan, P.R., Leigh, I.M., Purkis, P.E., Gardner, I.D., van Mujien, G.N.P., and Lane, D.B. Site variation in keratin gene expression in human oral epithelia. An immunohistochemical study of individual keratins. Epithelia, 7: 31-43, 1987.
49. Knapp, A.C., and Franke, W.W. Spontaneous losses of control of cytokeratin gene expression in transformed, non-epithelial human cells occurring at different levels of regulation. Cell, 59: 67-79, 1989.
50. Chung, K.Y., Mukhopadhyay, T., Kim, J., Casson, A., Ro, J.Y., Gopfert, H., Hong, W.K., and Roth, J.A. Discordant p. 3 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res., 53: 1676-1683, 1993.
51. Nowell, P.C. The clonal evolution of tumor cell populations. Science (Washington DC), 194: 23-26, 1976.
52. Fidler, I.J., and Kripke, M.D. Metastasis results from pre-existing variant cells within a malignant tumor. Science (Washington DC), 797: 893-895, 1977.
53. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M.L., Cavanee, W., and Vogelstein, B. Clonal expansion of p. 3 mutant cells is associated with brain tumor progression. Nature (Lond.), 355: 846-848, 1992.